Advances in High Throughput Proteomics Profiling in Establishing Potential Biomarkers for Gastrointestinal Cancer

Overview

Journal Cells

Publisher MDPI

Specialties Biochemistry
Biophysics
Cell Biology
Molecular Biology

Date 2022 Mar 25

PMID 35326424

Authors

Md Zahirul Islam Khan

Shing Yau Tam

Helen Ka Wai Law

Affiliations

Soon will be listed here.

Abstract

Gastrointestinal cancers (GICs) remain the most diagnosed cancers and accounted for the highest cancer-related death globally. The prognosis and treatment outcomes of many GICs are poor because most of the cases are diagnosed in advanced metastatic stages. This is primarily attributed to the deficiency of effective and reliable early diagnostic biomarkers. The existing biomarkers for GICs diagnosis exhibited inadequate specificity and sensitivity. To improve the early diagnosis of GICs, biomarkers with higher specificity and sensitivity are warranted. Proteomics study and its functional analysis focus on elucidating physiological and biological functions of unknown or annotated proteins and deciphering cellular mechanisms at molecular levels. In addition, quantitative analysis of translational proteomics is a promising approach in enhancing the early identification and proper management of GICs. In this review, we focus on the advances in mass spectrometry along with the quantitative and functional analysis of proteomics data that contributes to the establishment of biomarkers for GICs including, colorectal, gastric, hepatocellular, pancreatic, and esophageal cancer. We also discuss the future challenges in the validation of proteomics-based biomarkers for their translation into clinics.

Citing Articles

Multi-omics perspective: mechanisms of gastrointestinal injury repair.

Zhao H, Zhang Z, Liu H, Ma M, Sun P, Zhao Y Burns Trauma. 2025; 13():tkae057.

PMID: 39845194 PMC: 11752642. DOI: 10.1093/burnst/tkae057.

Biomarkers for Early Cancer Detection: A Landscape View of Recent Advancements, Spotlighting Pancreatic and Liver Cancers.

Tenchov R, Sapra A, Sasso J, Ralhan K, Tummala A, Azoulay N ACS Pharmacol Transl Sci. 2024; 7(3):586-613.

PMID: 38481702 PMC: 10928905. DOI: 10.1021/acsptsci.3c00346.

Novel biomarkers used for early diagnosis and tyrosine kinase inhibitors as targeted therapies in colorectal cancer.

Jiang H, Zhou S, Li G Front Pharmacol. 2023; 14:1189799.

PMID: 37719843 PMC: 10502318. DOI: 10.3389/fphar.2023.1189799.

Role of untargeted omics biomarkers of exposure and effect for tobacco research.

Shields P Addict Neurosci. 2023; 7.

PMID: 37396411 PMC: 10310069. DOI: 10.1016/j.addicn.2023.100098.

Artificial intelligence assists precision medicine in cancer treatment.

Liao J, Li X, Gan Y, Han S, Rong P, Wang W Front Oncol. 2023; 12:998222.

PMID: 36686757 PMC: 9846804. DOI: 10.3389/fonc.2022.998222.

References

Ho W, Hsu W, Huang M, Kadomatsu K, Nakagawara A . Protein glycosylation in cancers and its potential therapeutic applications in neuroblastoma. J Hematol Oncol. 2016; 9(1):100. PMC: 5041531. DOI: 10.1186/s13045-016-0334-6. View

Liu Q, Zhang H, Jiang X, Qian C, Liu Z, Luo D . Factors involved in cancer metastasis: a better understanding to "seed and soil" hypothesis. Mol Cancer. 2017; 16(1):176. PMC: 5712107. DOI: 10.1186/s12943-017-0742-4. View

Schubert O, Rost H, Collins B, Rosenberger G, Aebersold R . Quantitative proteomics: challenges and opportunities in basic and applied research. Nat Protoc. 2017; 12(7):1289-1294. DOI: 10.1038/nprot.2017.040. View

Wu X, Zhang Z, Chen X, Xu Y, Yin N, Yang J . A Panel of Three Biomarkers Identified by iTRAQ for the Early Diagnosis of Pancreatic Cancer. Proteomics Clin Appl. 2019; 13(5):e1800195. DOI: 10.1002/prca.201800195. View

Toby T, Fornelli L, Kelleher N . Progress in Top-Down Proteomics and the Analysis of Proteoforms. Annu Rev Anal Chem (Palo Alto Calif). 2016; 9(1):499-519. PMC: 5373801. DOI: 10.1146/annurev-anchem-071015-041550. View

Islam Khan M, Law H . Cancer Susceptibility Candidate 9 (CASC9) Promotes Colorectal Cancer Carcinogenesis via mTOR-Dependent Autophagy and Epithelial-Mesenchymal Transition Pathways. Front Mol Biosci. 2021; 8:627022. PMC: 8129023. DOI: 10.3389/fmolb.2021.627022. View

Kim K, Lee S, Hwang H, Lee J, Ji E, An H . Direct Monitoring of Fucosylated Glycopeptides of Alpha-Fetoprotein in Human Serum for Early Hepatocellular Carcinoma by Liquid Chromatography-Tandem Mass Spectrometry with Immunoprecipitation. Proteomics Clin Appl. 2018; 12(6):e1800062. DOI: 10.1002/prca.201800062. View

Liu J, Lin S, Li Z, Zhou L, Yan X, Xue Y . Free amino acid profiling of gastric juice as a method for discovering potential biomarkers of early gastric cancer. Int J Clin Exp Pathol. 2020; 11(5):2323-2336. PMC: 6958230. View

Zhang Z, Bast Jr R, Yu Y, Li J, Sokoll L, Rai A . Three biomarkers identified from serum proteomic analysis for the detection of early stage ovarian cancer. Cancer Res. 2004; 64(16):5882-90. DOI: 10.1158/0008-5472.CAN-04-0746. View

10.

Hasin Y, Seldin M, Lusis A . Multi-omics approaches to disease. Genome Biol. 2017; 18(1):83. PMC: 5418815. DOI: 10.1186/s13059-017-1215-1. View

11.

Alves Martins B, de Bulhoes G, Cavalcanti I, Martins M, de Oliveira P, Martins A . Biomarkers in Colorectal Cancer: The Role of Translational Proteomics Research. Front Oncol. 2019; 9:1284. PMC: 6890575. DOI: 10.3389/fonc.2019.01284. View

12.

Zhu J, Huang J, Zhang J, Chen Z, Lin Y, Grigorean G . Glycopeptide Biomarkers in Serum Haptoglobin for Hepatocellular Carcinoma Detection in Patients with Nonalcoholic Steatohepatitis. J Proteome Res. 2020; 19(8):3452-3466. PMC: 7429342. DOI: 10.1021/acs.jproteome.0c00270. View

13.

Locker G, Hamilton S, Harris J, Jessup J, Kemeny N, Macdonald J . ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer. J Clin Oncol. 2006; 24(33):5313-27. DOI: 10.1200/JCO.2006.08.2644. View

14.

Goossens N, Nakagawa S, Sun X, Hoshida Y . Cancer biomarker discovery and validation. Transl Cancer Res. 2015; 4(3):256-269. PMC: 4511498. DOI: 10.3978/j.issn.2218-676X.2015.06.04. View

15.

Kwon Y, Jo H, Bae S, Seo Y, Song P, Song M . Application of Proteomics in Cancer: Recent Trends and Approaches for Biomarkers Discovery. Front Med (Lausanne). 2021; 8:747333. PMC: 8492935. DOI: 10.3389/fmed.2021.747333. View

16.

Kailemia M, Park D, Lebrilla C . Glycans and glycoproteins as specific biomarkers for cancer. Anal Bioanal Chem. 2016; 409(2):395-410. PMC: 5203967. DOI: 10.1007/s00216-016-9880-6. View

17.

Heo C, Hwang H, Lee H, Kwak S, Yoo J, Yu D . Serum anti-EIF3A autoantibody as a potential diagnostic marker for hepatocellular carcinoma. Sci Rep. 2019; 9(1):11059. PMC: 6667438. DOI: 10.1038/s41598-019-47365-4. View

18.

Ivancic M, Megna B, Sverchkov Y, Craven M, Reichelderfer M, Pickhardt P . Noninvasive Detection of Colorectal Carcinomas Using Serum Protein Biomarkers. J Surg Res. 2019; 246:160-169. PMC: 6957232. DOI: 10.1016/j.jss.2019.08.004. View

19.

Bhardwaj M, Gies A, Weigl K, Tikk K, Benner A, Schrotz-King P . Evaluation and Validation of Plasma Proteins Using Two Different Protein Detection Methods for Early Detection of Colorectal Cancer. Cancers (Basel). 2019; 11(10). PMC: 6826652. DOI: 10.3390/cancers11101426. View

20.

Allen D, McWhinney B . Quadrupole Time-of-Flight Mass Spectrometry: A Paradigm Shift in Toxicology Screening Applications. Clin Biochem Rev. 2019; 40(3):135-146. PMC: 6719743. DOI: 10.33176/AACB-19-00023. View